Harvard Medical School-Pharmaceuticals & Healthcare-Deals and Alliances Profile

Harvard Medical School-Pharmaceuticals & Healthcare-Deals and Alliances Profile


  • Products Id :- GDPH199004D
  • |
  • Pages: 57
  • |
  • |
  • |
  Request for Sample Report
  Request A Quote

Executive Summary

Summary

Harvard Medical School (HMS), a subsidiary of Harvard University is a medical institute that offers education, research and clinical care services. The institute offers various degree programs such as bachelor's program, master's program, PhD program, and continuing education. It offers programs in the areas of medical education, health sciences and technology, and medicine. HMS also conducts basic and clinical research studies. The institute offers healthcare services in the fields of anaesthesia, otology and laryngology, pathology, dermatology, pediatrics, emergency medicine, physical medicine and rehabilitation, among others. It operates through medical centers, hospital, and research institutes in Massachusetts. HMS is headquartered in Boston, Massachusetts, the US.

Harvard Medical School-Pharmaceuticals & Healthcare-Deals and Alliances Profile provides you comprehensive data and trend analysis of the company's Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.

Scope

Financial Deals-Analysis of the company's financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.

Deals by Year-Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.

Deals by Type-Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.

Deals by Region-Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.

Deals by Sub-sector-Chart and table showing information on the number of deals and value reported by the company, by sub-sector.

Major Deals-Information on the company's major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company's (major public companies) key financial metrics and ratios.

Business Description-A brief description of the company's operations.

Key Employees-A list of the key executives of the company.

Important Locations and Subsidiaries-A list and contact details of key centers of operation and subsidiaries of the company.

Key Competitors-A list of the key competitors of the company.

Key Recent Developments-A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company's financial deals that enable you to understand the company's expansion/divestiture and fund requirements

The profile enables you to analyze the company's financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company's business segments' expansion / divestiture strategy

The profile presents deals from the company's core business segments' perspective to help you understand its corporate strategy.

Access elaborate information on the company's recent financial deals that enable you to understand the key deals which have shaped the company

Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company's key financial metrics and ratios.

Equip yourself with detailed information about the company's operations to identify potential customers and suppliers.

The profile analyzes the company's business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company

Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research

Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.



Read More



Contact Us:
Ken Research
Ankur Gupta, Head Marketing & Communications

+91-9015378249

Table of Contents

Table of Contents

List of Tables

List of Figures

Harvard Medical School, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018

Harvard Medical School, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018

Harvard Medical School, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018

Harvard Medical School, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018

Harvard Medical School, Medical Devices Deals, 2012 to YTD 2018

Harvard Medical School, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018

Harvard Medical School, Pharmaceuticals & Healthcare, Deal Details

Partnerships

ConSynance Therapeutics Enters into Research Agreement with Harvard Medical School

Imcare Biotech Enters into Partnership with Harvard Medical School

Astellas Pharma Enters into Research Agreement with Harvard Medical School

Genocea Biosciences Enters Into Research Agreement With Dana-Farber Cancer Institute And Harvard Medical School

Genia Technologies Enters Into Agreement With Columbia University And Harvard Medical To Develop NanoTag DNA Sequencing Technology

Ipsen Enters Into Research Agreement With Harvard Medical School To Discover Botulinum Toxins

Licensing Agreements

X-Biotix Therapeutics Enters into Licensing Agreement with Harvard Medical School

Frequency Therapeutics Receives Intellectual Property Rights from MIT and Harvard Medical School

Juniper Pharma Enters into Licensing Agreement with Harvard Medical, Massachusetts General Hospital and Massachusetts Institute of Technology

Columbia Labs Enters into Licensing Agreement for IVR Technology

Mesoblast Enters into Licensing Agreement with Harvard Medical School

GNS Healthcare Enters Into Licensing Agreement With Harvard Medical School

Harvard Medical School-Key Competitors

Harvard Medical School-Key Employees

Harvard Medical School-Locations And Subsidiaries

Head Office

Other Locations & Subsidiaries

Joint Venture

Recent Developments

Government and Public Interest

Feb 15, 2018: Baylor team shortlisted for Cancer Research UK grants

Jan 04, 2018: Researchers create novel compound targeting melanoma cells

Dec 11, 2017: USC, Harvard-affiliated hospitals & Mayo Clinic team up to streamline Alzheimer's research

Nov 30, 2017: Invasive cells in head and neck tumors predict cancer spread

Nov 29, 2017: Researchers Develop New Technique to Model Transplantation of the Human Liver

Nov 28, 2017: RSNA Release: Fat Distribution in Women and Men Provides Clues to Heart Attack Risk

Oct 31, 2017: From Bench to Bedside: $4 Million Gift Supports Translational Medicine

Oct 18, 2017: New study reveals breast cancer cells recycle their own ammonia waste as fuel

Oct 09, 2017: New Congenital Heart Disease Genes Uncovered

Sep 15, 2017: New Study on the Placebo Effect and Antidepressants in Children and Adolescents

Sep 11, 2017: Scientists Construct First Predictive Model of Inflammatory Bowel Disease

Aug 31, 2017: Role of gut bacteria in averting Type 1 diabetes

Aug 21, 2017: Massachusetts Eye and Ear: Researchers identify key compounds to resolve abnormal vascular growth in age-related macular degeneration

Aug 14, 2017: Breakthrough Study By Pancreatic Cancer Action Network Grantee Evaluates Tumor Growth In Obese Vs. Lean Mice

Jul 19, 2017: DARPA: Building the Safe Genes Toolkit

Jun 27, 2017: Individualizing deep brain stimulation in patients with Parkinson's disease

Apr 11, 2017: Researchers identify new target for abnormal blood vessel growth in the eyes

Feb 07, 2017: Cystinosis Research Foundation Grants Support Scientific Studies on Cell Function, New Treatments and the Quest for a Cure

Appendix

Methodology

About GlobalData

Contact Us

Disclaimer

List of Figures

Harvard Medical School, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018

Harvard Medical School, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018

Harvard Medical School, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018

Harvard Medical School, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018

Harvard Medical School, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018

Harvard Medical School, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018

Harvard Medical School, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018

Harvard Medical School, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018

Harvard Medical School, Medical Devices Deals, 2012 to YTD 2018

List of Tables

Harvard Medical School, Pharmaceuticals & Healthcare, Key Facts

Harvard Medical School, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018

Harvard Medical School, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018

Harvard Medical School, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018

Harvard Medical School, Deals By Therapy Area, 2012 to YTD 2018

Harvard Medical School, Medical Devices Deals, 2012 to YTD 2018

Harvard Medical School, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018

ConSynance Therapeutics Enters into Research Agreement with Harvard Medical School

Imcare Biotech Enters into Partnership with Harvard Medical School

Astellas Pharma Enters into Research Agreement with Harvard Medical School

Genocea Biosciences Enters Into Research Agreement With Dana-Farber Cancer Institute And Harvard Medical School

Genia Technologies Enters Into Agreement With Columbia University And Harvard Medical To Develop NanoTag DNA Sequencing Technology

Ipsen Enters Into Research Agreement With Harvard Medical School To Discover Botulinum Toxins

X-Biotix Therapeutics Enters into Licensing Agreement with Harvard Medical School

Frequency Therapeutics Receives Intellectual Property Rights from MIT and Harvard Medical School

Juniper Pharma Enters into Licensing Agreement with Harvard Medical, Massachusetts General Hospital and Massachusetts Institute of Technology

Columbia Labs Enters into Licensing Agreement for IVR Technology

Mesoblast Enters into Licensing Agreement with Harvard Medical School

GNS Healthcare Enters Into Licensing Agreement With Harvard Medical School

Harvard Medical School, Key Competitors

Harvard Medical School, Key Employees

Harvard Medical School, Subsidiaries

Harvard Medical School, Joint Venture

Single User License:
Report can be used by individual purchaser only

Site License:
Report can be shared by unlimited users within one corporate location, e.g. a regional office

Corporate User License:
Report can be shared globally by unlimited users within the purchasing corporation e.g. all employees of a single company

To know more information on Purchase by Section, please send a mail to sales [@] kenresearch.com
 

select a license

Single User License
USD 250 INR 18130
Site License
USD 500 INR 36260
Corporate User License
USD 750 INR 54390

NEWSLETTER BY CATEGORY




Testimonials

An excellent provider. Thorough, precise and outstanding insight. They drill down to what we need and their reports are effective at integrating text with supporting graphics and charts. Their reports are a great resource to go back too. ...

Coherent, high-quality, thoroughly-researched reports. We received a very quick response to all our queries which eventually expedited the entire process....

Well structured, the insights they shared with us were very helpful and reliable. Their timely assistance make their services invaluable to us. I would highly recommend them and would definitely use them again in the future if needed...

The report sent to us was on the point, and its information was quite extensive, well structured, and well researched. More importantly what we valued was your response time and professionalism. As a leading global consulting firm, our clients expect high quality deliverables in short periods of time, so a reliable research partner is essential. For the price that you have charged the quality of your services were exceptional. We look forward to continue our relationship with your team on future engagements....

This is with regards to your report on India PVC pipes and fitting market outlook industry outlook to 2019. This is a very well written report and accept my compliments on the same.... ...



Ken Research, Unit 14, Tower B3, Spaze I Tech Business Park, Sohna Road, sector 49
     Gurgaon, Haryana - 122001, India

download

Company Brochure

Engage with Us

sales [@] kenresearch.com